These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28381180)

  • 1. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
    Hromadnikova I; Kotlabova K; Krofta L; Hron F
    Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.
    Hromadnikova I; Kotlabova K; Hympanova L; Doucha J; Krofta L
    PLoS One; 2014; 9(12):e113735. PubMed ID: 25502889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
    Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
    PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Ondrackova M; Pirkova P; Kestlerova A; Novotna V; Hympanova L; Krofta L
    DNA Cell Biol; 2015 Jun; 34(6):437-57. PubMed ID: 25825993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
    Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
    Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
    DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.
    Hromadnikova I; Kotlabova K; Ondrackova M; Kestlerova A; Novotna V; Hympanova L; Doucha J; Krofta L
    Mediators Inflamm; 2013; 2013():186041. PubMed ID: 24347821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
    Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
    Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential.
    Kotlabova K; Doucha J; Hromadnikova I
    J Reprod Immunol; 2011 May; 89(2):185-91. PubMed ID: 21513988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia.
    Miura K; Higashijima A; Murakami Y; Tsukamoto O; Hasegawa Y; Abe S; Fuchi N; Miura S; Kaneuchi M; Masuzaki H
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1526-32. PubMed ID: 26224638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications.
    Hromadnikova I; Kotlabova K; Doucha J; Dlouha K; Krofta L
    J Mol Diagn; 2012; 14(2):160-7. PubMed ID: 22251611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNA signature in the progression of gestational trophoblastic disease.
    Zhao JR; Cheng WW; Wang YX; Cai M; Wu WB; Zhang HJ
    Cell Death Dis; 2018 Jan; 9(2):94. PubMed ID: 29367697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
    Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
    Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
    Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
    Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of severe preeclampsia and intrauterine growth restriction based on serum placental exosome miR-520a-5p levels during the first-trimester.
    Xu XR; Cheng L; Wang YP
    Medicine (Baltimore); 2024 May; 103(20):e38188. PubMed ID: 38758859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth.
    Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
    Mol Med Rep; 2017 Oct; 16(4):3849-3862. PubMed ID: 28731129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of placenta-specific microRNAs in maternal circulation].
    Hromadníková I; Kotlabová K; Jirásek JE; Doucha J
    Ceska Gynekol; 2010 May; 75(3):252-6. PubMed ID: 20731307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the clinical laboratory detection of gestational trophoblastic disease.
    Seki K; Matsui H; Sekiya S
    Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.